TC
FLNA

TFS Capital’s Filana Therapeutics FLNA Stock Holding History

TFS Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,643
Closed -$20K – 1084
2015
Q4 		$20K Sell
1,643
-325
-17% -$4.3K ﹤0.01% 728
2015
Q3 		$25K Sell
1,968
-4,027
-67% -$50.8K ﹤0.01% 867
2015
Q2 		$73K Buy
+5,995
New +$82.1K 0.01% 835
2015
Q1 		– Sell
-2,537
Closed -$36K – 1110
2014
Q4 		$36K Buy
+2,537
New +$43.9K ﹤0.01% 954
2014
Q3 		– Sell
-41,719
Closed -$1.68M – 1186
2014
Q2 		$1.68M Sell
41,719
-6,989
-14% -$259K 0.13% 233
2014
Q1 		$1.88M Buy
48,708
+5,830
+14% +$206K 0.12% 239
2013
Q4 		$1.46M Buy
42,878
+28,790
+204% +$764K 0.07% 417
2013
Q3 		$268K Sell
14,088
-16,748
-54% -$293K 0.01% 1145
2013
Q2 		$477K Buy
+30,836
New +$652K 0.02% 921

Other funds holding FLNA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

TFS Capital's FLNA Position: Q1 2016 in Review

TFS Capital sold out of Filana Therapeutics (FLNA) in Q1 2016, closing a stake of 1,643 shares — an estimated $20K sold.

TFS Capital first reported a position in FLNA in Q2 2013 and held it in 9 quarters. The position peaked at $1.88M in Q1 2014. 44 funds tracked by Wall St. Rank hold FLNA as of Q1 2016.

  • TFS Capital reported no remaining Filana Therapeutics position as of Q1 2016 after selling out during the quarter.
  • TFS Capital sold 1,643 Filana Therapeutics shares in Q1 2016, an estimated $20K.
  • TFS Capital first reported a position in Filana Therapeutics in Q2 2013 and held it in 9 quarters.
  • TFS Capital's Filana Therapeutics position peaked at $1.88M in Q1 2014.
  • 44 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2016.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.